PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer.
Cancers (Basel)
; 14(2)2022 Jan 08.
Article
in En
| MEDLINE
| ID: mdl-35053470
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Cancers (Basel)
Year:
2022
Type:
Article
Affiliation country:
France